Norman Tse
Direktor/Vorstandsmitglied bei Bio-Cancer Treatment International Ltd.
Aktive Positionen von Norman Tse
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Nan Fung Life Sciences
Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences (Nan Fung Life Sciences) is a venture capital subsidiary of Vervain Group (Holdings) Ltd founded in 1954 by Vincent Cheung. The firm is headquartered in Hong Kong. | Private-Equity-Analyst | 01.10.2017 | - |
Private Equity Investor | 01.10.2017 | - | |
Bio-Cancer Treatment International Ltd.
Bio-Cancer Treatment International Ltd. BiotechnologyHealth Technology Bio-Cancer Treatment International Ltd. is a Chinese company that focuses on researching and developing biological products and therapeutics for cancer and auto immune disorders. The company is based in Hong Kong, Hong Kong. The company was founded in 2000 by Jun Sing Lee and Paul Cheng, with Paul Cheng serving as the CEO since its inception. | Direktor/Vorstandsmitglied | 01.06.2019 | - |
Karriereverlauf von Norman Tse
Statistik
International
Vereinigte Staaten | 2 |
Hong Kong | 2 |
Operativ
Private Equity Analyst | 1 |
Private Equity Investor | 1 |
Director/Board Member | 1 |
Sektoral
Finance | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Nan Fung Life Sciences
Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences (Nan Fung Life Sciences) is a venture capital subsidiary of Vervain Group (Holdings) Ltd founded in 1954 by Vincent Cheung. The firm is headquartered in Hong Kong. | Finance |
Bio-Cancer Treatment International Ltd.
Bio-Cancer Treatment International Ltd. BiotechnologyHealth Technology Bio-Cancer Treatment International Ltd. is a Chinese company that focuses on researching and developing biological products and therapeutics for cancer and auto immune disorders. The company is based in Hong Kong, Hong Kong. The company was founded in 2000 by Jun Sing Lee and Paul Cheng, with Paul Cheng serving as the CEO since its inception. | Health Technology |
- Börse
- Insiders
- Norman Tse
- Erfahrung